Dunaharaszti, Hungary

Tamás Visnovitz


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Lipid Quantification: The Contributions of Tamás Visnovitz

Introduction

Tamás Visnovitz is an innovative inventor based in Dunaharaszti, Hungary. He has made significant contributions to the field of biomedicine, particularly in the quantification of extracellular vesicles (EVs). His work addresses a critical need for reliable methods in EV research, which is gaining traction due to the potential of EVs to serve as biomarkers for various diseases.

Latest Patents

Visnovitz holds a patent for a method that determines the lipid content of extracellular vesicles. This method is crucial as it focuses on the defining component of EVs, the lipid bilayer, rather than relying solely on protein measurements, which can lead to overestimations of EV concentration. The invention provides a reliable, quick, and cost-effective approach for standardizing EV experiments in laboratories equipped with basic tools such as a fume hood, thermoblock, and spectrophotometer.

Career Highlights

Tamás Visnovitz is affiliated with Semmelweis University, where he continues to advance research in the field of extracellular vesicles. His work is pivotal in enhancing the understanding of EVs and their roles in biological processes. With a focus on lipid quantification, his contributions are expected to facilitate further research and applications in biomedicine.

Collaborations

Visnovitz collaborates with notable colleagues, including Xabier Osteikoetxea Velez and Edit Irén Buzás. These collaborations enhance the research output and foster innovation in the study of extracellular vesicles.

Conclusion

Tamás Visnovitz's innovative approach to lipid quantification in extracellular vesicles represents a significant advancement in biomedicine. His patent and ongoing research contribute to the standardization and accuracy of EV studies, paving the way for future discoveries in disease biomarkers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…